LANGLEY, BC / ACCESSWIRE / August 17, 2022 / Adastra Holdings Ltd. CSE:XTRXFRA:D2EP "Adastra" or the "Company", a leading cannabis company focused on processing, product development, sales, organoleptic testing and analytical testing, is pleased to announce it has received its Medical Sales License from Health Canada which now authorizes Adastra to sell cannabinoidcontaining... Lire le communiqué |